Rethinking rare diseases: treat the whole patient
Our CEO Kay Parkinson believes experts need to work together to address the unmet needs in rare disease research and treatment and abandon the siloed approach that fails patients and their families. Read her article her article from Pharmaphorum magazine here.
Dive straight into the feedback!Login below and you can start commenting using your own user instantly